Viral persistence: HIV's strategies of immune system evasion

被引:159
作者
Johnson, WE [1 ]
Desrosiers, RC [1 ]
机构
[1] New England Reg Primate Res Ctr, Southborough, MA 01772 USA
来源
ANNUAL REVIEW OF MEDICINE | 2002年 / 53卷
关键词
SIV; AIDS vaccine; antigenic escape; neutralizing antibody; lentivirus;
D O I
10.1146/annurev.med.53.082901.104053
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In contrast to most animal viruses, infection with the human and simian immunodeficiency viruses results in prolonged, continuous viral replication in the infected host. Remarkably, viral persistence is not thwarted by the presence of apparently vigorous, virus-specific immune responses. Several factors are thought to contribute to persistent viral replication, most notably the destruction of virus-specific T helper cells, the emergence of antigenic escape variants, and the expression of an envelope complex that structurally minimizes antibody access to conserved epitopes. Not as well understood, though potentially important, is the ability of at least one viral encoded protein (Nef) to prevent presentation of viral antigens in the context of major histocompatibility complex. The future success of antiviral therapies and vaccination strategies may depend largely on understanding how and to what degree each of these factors (and presumably others) contributes to immune evasion.
引用
收藏
页码:499 / 518
页数:20
相关论文
共 133 条
  • [1] ADA G, 1999, VACCINES, P28
  • [2] AHMED R, 1996, FIELDS VIROLOGY, P219
  • [3] RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA
    ALBERT, J
    ABRAHAMSSON, B
    NAGY, K
    AURELIUS, E
    GAINES, H
    NYSTROM, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (02) : 107 - 112
  • [4] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [5] IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE
    ANDERSSON, M
    PAABO, S
    NILSSON, T
    PETERSON, PA
    [J]. CELL, 1985, 43 (01) : 215 - 222
  • [6] Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: Isolation of a neutralization escape variant
    Andrus, L
    Prince, AM
    Bernal, I
    McCormack, P
    Lee, DH
    Gorny, MK
    Zolla-Pazner, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) : 889 - 897
  • [7] ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
  • [8] Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
    Baba, TW
    Liska, V
    Hofmann-Lehmann, R
    Vlasak, J
    Xu, WD
    Ayehunie, S
    Cavacini, LA
    Posner, MR
    Katinger, H
    Stiegler, G
    Bernacky, BJ
    Rizvi, TA
    Schmidt, R
    Hill, LR
    Keeling, ME
    Lu, YC
    Wright, JE
    Chou, TC
    Ruprecht, RM
    [J]. NATURE MEDICINE, 2000, 6 (02) : 200 - 206
  • [9] AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION
    BACK, NKT
    SMIT, L
    DEJONG, JJ
    KEULEN, W
    SCHUTTEN, M
    GOUDSMIT, J
    TERSMETTE, M
    [J]. VIROLOGY, 1994, 199 (02) : 431 - 438
  • [10] Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation
    Bandres, JC
    Wang, QF
    O'Leary, J
    Baleaux, F
    Amara, A
    Hoxie, JA
    Zolla-Pazner, S
    Gorny, MK
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2500 - 2504